Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review

被引：21

作者：

Karadeniz, Hazan ^{[1
]}

Guler, Aslihan Avanoglu ^{[1
]}

Atas, Nuh ^{[1
]}

Satis, Hasan ^{[1
]}

Salman, Reyhan Bilici ^{[1
]}

Babaoglu, Hakan ^{[1
]}

Tufan, Abdurrahman ^{[1
]}

机构：

[1] Gazi Univ, Fac Med, Dept Internal Med, Div Rheumatol, TR-06100 Ankara, Turkey

来源：

RHEUMATOLOGY INTERNATIONAL | 2020年 / 40卷 / 01期

关键词：

Familial Mediterranean fever; Auto-inflammatory disease; Spondylarthritis; Tofacitinib; Janus kinase (JAK) inhibitor;

D O I：

10.1007/s00296-019-04490-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Familial Mediterranean fever is characterized by self-limited attacks of serositis and arthritis. However, substantial number of patients suffer from chronic complications of this disease, primarily involving musculoskeletal system. Treatment for these complications is challenging due to limited evidence. Interleukin-1 (IL-1) antagonists, tocilizumab and anti-tumor necrosis factor (anti-TNF) agents are off-label treatment options for the management of chronic manifestations of FMF, such as secondary (AA) amyloidosis, chronic arthritis and sacroiliitis. This paper presents a case series of four FMF patients who are refractory to IL-1 antagonists, anti-TNF agents and tocilizumab, who responded well to tofacitinib. The authors also conducted a comprehensive literature search for studies investigating tofacitinib use in FMF patients. Although still limited, current data suggest that tofacitinib could be a useful treatment option for FMF patients with associated inflammatory comorbid conditions and chronic manifestations of disease.

引用

页码：169 / 173

页数：5

共 11 条

[1] High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection [J].

Akar, Servet ;

Soysal, Ozgul ;

Balci, Ali ;

Solmaz, Dilek ;

Gerdan, Vedat ;

Onen, Fatos ;

Tunca, Mehmet ;

Akkoc, Nurullah .

ARTHRITIS RESEARCH & THERAPY, 2013, 15 (01)

[2] Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study [J].

Atas, Nuh ;

Armagan, Berkan ;

Bodakci, Erdal ;

Satis, Hasan ;

Sari, Alper ;

Bilge, Nazife Sule Yasar ;

Salman, Reyhan Bilici ;

Yardimci, Gozde Kubra ;

Babaoglu, Hakan ;

Guler, Aslihan Avanoglu ;

Karadeniz, Hazan ;

Kilic, Levent ;

Ozturk, Mehmet Akif ;

Goker, Berna ;

Haznedaroglu, Seminur ;

Kalyoncu, Umut ;

Kasifoglu, Timucin ;

Tufan, Abdurrahman .

RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) :41-48

[3] Tofacitinib for familial Mediterranean fever: a new alternative therapy? [J].

Garcia-Robledo, Juan Esteban ;

Aragon, Cristian C. ;

Nieto-Aristizabal, Ivana ;

Posso-Osorio, Ivan ;

Canas, Carlos A. ;

Tobon, Gabriel J. .

RHEUMATOLOGY, 2019, 58 (03) :553-554

[4]

Gök K, 2017, ACTA REUMATOL PORT, V42, P88

[5]

Gumucio DL, 2002, CLIN EXP RHEUMATOL, V20, pS45

[6] Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial [J].

Hashkes, Philip J. ;

Spalding, Steven J. ;

Giannini, Edward H. ;

Huang, Bin ;

Johnson, Anne ;

Park, Grace ;

Barron, Karyl S. ;

Weisman, Michael H. ;

Pashinian, Noune ;

Reiff, Andreas O. ;

Samuels, Jonathan ;

Wright, Dowain A. ;

Kastner, Daniel L. ;

Lovell, Daniel J. .

ANNALS OF INTERNAL MEDICINE, 2012, 157 (08) :533-+

[7]

Kiraz S, 1998, CLIN EXP RHEUMATOL, V16, P721

[8] Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever [J].

Koga, Tomohiro ;

Migita, Kiyoshi ;

Sato, Shuntaro ;

Umeda, Masataka ;

Nonaka, Fumiaki ;

Kawashiri, Shin-Ya ;

Iwamoto, Naoki ;

Ichinose, Kunihiro ;

Tamai, Mami ;

Nakamura, Hideki ;

Origuchi, Tomoki ;

Ueki, Yukitaka ;

Masumoto, Junya ;

Agematsu, Kazunaga ;

Yachie, Akihiro ;

Yoshiura, Koh-Ichiro ;

Eguchi, Katsumi ;

Kawakami, Atsushi .

MEDICINE, 2016, 95 (16)

[9] The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells [J].

Maeshima, Keisuke ;

Yamaoka, Kunihiro ;

Kubo, Satoshi ;

Nakano, Kazuhisa ;

Iwata, Shigeru ;

Saito, Kazuyoshi ;

Ohishi, Masanobu ;

Miyahara, Hisaaki ;

Tanaka, Shinya ;

Ishii, Koji ;

Yoshimatsu, Hironobu ;

Tanaka, Yoshiya .

ARTHRITIS AND RHEUMATISM, 2012, 64 (06) :1790-1798

[10] Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis [J].

Meyer, Debra M. ;

Jesson, Michael I. ;

Li, Xiong ;

Elrick, Mollisa M. ;

Funckes-Shippy, Christie L. ;

Warner, James D. ;

Gross, Cindy J. ;

Dowty, Martin E. ;

Ramaiah, Shashi K. ;

Hirsch, Jeffrey L. ;

Saabye, Matthew J. ;

Barks, Jennifer L. ;

Kishore, Nandini ;

Morris, Dale L. .

JOURNAL OF INFLAMMATION-LONDON, 2010, 7

← 1 2 →